These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Exposure of the HIV-1 broadly neutralizing antibody 10E8 MPER epitope on the membrane surface by gp41 transmembrane domain scaffolds. Oakes V, Torralba J, Rujas E, Nieva JL, Domene C, Apellaniz B. Biochim Biophys Acta Biomembr; 2018 Jun 15; 1860(6):1259-1271. PubMed ID: 29477358 [Abstract] [Full Text] [Related]
3. Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design. Irimia A, Serra AM, Sarkar A, Jacak R, Kalyuzhniy O, Sok D, Saye-Francisco KL, Schiffner T, Tingle R, Kubitz M, Adachi Y, Stanfield RL, Deller MC, Burton DR, Schief WR, Wilson IA. PLoS Pathog; 2017 Feb 15; 13(2):e1006212. PubMed ID: 28225819 [Abstract] [Full Text] [Related]
4. Antibody to gp41 MPER alters functional properties of HIV-1 Env without complete neutralization. Kim AS, Leaman DP, Zwick MB. PLoS Pathog; 2014 Jul 15; 10(7):e1004271. PubMed ID: 25058619 [Abstract] [Full Text] [Related]
5. Mechanism of HIV-1 neutralization by antibodies targeting a membrane-proximal region of gp41. Chen J, Frey G, Peng H, Rits-Volloch S, Garrity J, Seaman MS, Chen B. J Virol; 2014 Jan 15; 88(2):1249-58. PubMed ID: 24227838 [Abstract] [Full Text] [Related]
6. Enhancing HIV-1 Neutralization by Increasing the Local Concentration of Membrane-Proximal External Region-Directed Broadly Neutralizing Antibodies. Kim S, Filsinger Interrante MV, Kim PS. J Virol; 2023 Jan 31; 97(1):e0164722. PubMed ID: 36541800 [Abstract] [Full Text] [Related]
7. Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region. Banerjee S, Shi H, Banasik M, Moon H, Lees W, Qin Y, Harley A, Shepherd A, Cho MW. Virology; 2017 May 31; 505():113-126. PubMed ID: 28237764 [Abstract] [Full Text] [Related]
8. Structural basis for broad neutralization of HIV-1 through the molecular recognition of 10E8 helical epitope at the membrane interface. Rujas E, Caaveiro JM, Partida-Hanon A, Gulzar N, Morante K, Apellániz B, García-Porras M, Bruix M, Tsumoto K, Scott JK, Jiménez MÁ, Nieva JL. Sci Rep; 2016 Dec 01; 6():38177. PubMed ID: 27905530 [Abstract] [Full Text] [Related]
9. Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01. Pinto D, Fenwick C, Caillat C, Silacci C, Guseva S, Dehez F, Chipot C, Barbieri S, Minola A, Jarrossay D, Tomaras GD, Shen X, Riva A, Tarkowski M, Schwartz O, Bruel T, Dufloo J, Seaman MS, Montefiori DC, Lanzavecchia A, Corti D, Pantaleo G, Weissenhorn W. Cell Host Microbe; 2019 Nov 13; 26(5):623-637.e8. PubMed ID: 31653484 [Abstract] [Full Text] [Related]
10. Cholesterol-dependent membrane fusion induced by the gp41 membrane-proximal external region-transmembrane domain connection suggests a mechanism for broad HIV-1 neutralization. Apellániz B, Rujas E, Carravilla P, Requejo-Isidro J, Huarte N, Domene C, Nieva JL. J Virol; 2014 Nov 13; 88(22):13367-77. PubMed ID: 25210180 [Abstract] [Full Text] [Related]
11. Effect of diversity in gp41 membrane proximal external region of primary HIV-1 Indian subtype C sequences on interaction with broadly neutralizing antibodies 4E10 and 10E8. Sutar J, Padwal V, Sonawani A, Nagar V, Patil P, Kulkarni B, Hingankar N, Deshpande S, Idicula-Thomas S, Jagtap D, Bhattacharya J, Bandivdekar A, Patel V. Virus Res; 2019 Nov 13; 273():197763. PubMed ID: 31553924 [Abstract] [Full Text] [Related]
12. Topological analysis of the gp41 MPER on lipid bilayers relevant to the metastable HIV-1 envelope prefusion state. Wang Y, Kaur P, Sun ZJ, Elbahnasawy MA, Hayati Z, Qiao ZS, Bui NN, Chile C, Nasr ML, Wagner G, Wang JH, Song L, Reinherz EL, Kim M. Proc Natl Acad Sci U S A; 2019 Nov 05; 116(45):22556-22566. PubMed ID: 31624123 [Abstract] [Full Text] [Related]
13. Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency. Jacob RA, Moyo T, Schomaker M, Abrahams F, Grau Pujol B, Dorfman JR. J Virol; 2015 May 05; 89(10):5264-75. PubMed ID: 25673728 [Abstract] [Full Text] [Related]
14. Functional Delineation of a Protein-Membrane Interaction Hotspot Site on the HIV-1 Neutralizing Antibody 10E8. Insausti S, Garcia-Porras M, Torralba J, Morillo I, Ramos-Caballero A, de la Arada I, Apellaniz B, Caaveiro JMM, Carravilla P, Eggeling C, Rujas E, Nieva JL. Int J Mol Sci; 2022 Sep 15; 23(18):. PubMed ID: 36142694 [Abstract] [Full Text] [Related]
15. Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape. Wibmer CK, Gorman J, Ozorowski G, Bhiman JN, Sheward DJ, Elliott DH, Rouelle J, Smira A, Joyce MG, Ndabambi N, Druz A, Asokan M, Burton DR, Connors M, Abdool Karim SS, Mascola JR, Robinson JE, Ward AB, Williamson C, Kwong PD, Morris L, Moore PL. PLoS Pathog; 2017 Jan 15; 13(1):e1006074. PubMed ID: 28076415 [Abstract] [Full Text] [Related]
16. 10E8-like neutralizing antibodies against HIV-1 induced using a precisely designed conformational peptide as a vaccine prime. Yu Y, Tong P, Li Y, Lu Z, Chen Y. Sci China Life Sci; 2014 Jan 15; 57(1):117-27. PubMed ID: 24369352 [Abstract] [Full Text] [Related]
17. Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4E10. Rujas E, Gulzar N, Morante K, Tsumoto K, Scott JK, Nieva JL, Caaveiro JM. J Virol; 2015 Dec 15; 89(23):11975-89. PubMed ID: 26378169 [Abstract] [Full Text] [Related]